[A new combination therapy for diabetic gastroparesis]

Area of Science:

• Gastroenterology
• Endocrinology
• Medical Devices

Background:

• Diabetic gastroparesis is a common complication of diabetes mellitus, leading to significant gastrointestinal dysfunction.
• Therapy-refractory diabetic gastroparesis presents a challenge, with limited effective treatment options.
• Current treatments often fail to adequately address severe symptoms and delayed gastric emptying.

Observation:

• A novel combination therapy involving gastric electric stimulation (GES) and botulinus toxin (BTX) injection into the pylorus was administered to a patient with severe symptomatic diabetic gastroparesis.
• The treatment was prospectively documented over 18 months.
• No complications were observed during the treatment period.

Findings:

• The combination therapy resulted in a dramatic improvement in the gastroparesis symptom score.
• Gastric emptying, assessed by scintigraphy, showed only a minor decrease in the time to 50% emptying (t½).
• Symptomatic relief was sustained for at least 18 months.

Implications:

• This combination therapy represents a potential new treatment strategy for therapy-refractory diabetic gastroparesis.
• The findings suggest that symptomatic improvement may not directly correlate with significant changes in gastric emptying rates.
• Further prospective studies are warranted to validate the effectiveness and long-term outcomes of this combined therapeutic approach.